Cargando…
Use of chlorprothixene and the risk of diabetes and major adverse cardiovascular events: A nationwide cohort study
Chlorprothixene is commonly used off‐label in low doses for sedative‐hypnotic purposes although it might carry a risk of cardiometabolic adverse events due to its pharmacodynamic profile. We investigated the risk of diabetes and major adverse cardiovascular events (MACE) with use of low‐dose chlorpr...
Autores principales: | Højlund, Mikkel, Wagner, Christina Blanner, Wesselhoeft, Rikke, Andersen, Kjeld, Fink‐Jensen, Anders, Hallas, Jesper |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303779/ https://www.ncbi.nlm.nih.gov/pubmed/35122399 http://dx.doi.org/10.1111/bcpt.13711 |
Ejemplares similares
-
Impact of low‐dose quetiapine‐use on glycosylated hemoglobin, triglyceride and cholesterol levels
por: Højlund, Mikkel, et al.
Publicado: (2022) -
Association of Low-Dose Quetiapine and Diabetes
por: Højlund, Mikkel, et al.
Publicado: (2021) -
Free‐of‐charge dispensing of antipsychotics for schizophrenia in Denmark: Impact on the nationwide prescription registry and redemption of somatic medications
por: Rohde, Christopher, et al.
Publicado: (2022) -
Association of Prior Intracerebral Hemorrhage With Major Adverse Cardiovascular Events
por: Gaist, David, et al.
Publicado: (2022) -
Development and Validation of a Nordic Multimorbidity Index Based on Hospital Diagnoses and Filled Prescriptions
por: Kristensen, Kasper Bruun, et al.
Publicado: (2022)